PYC Therapeutics (ASX:PYC) Retained Earnings: A$-229.03 Mil (As of Dec. 2025)


ASX:PYC PYC Therapeutics Ltd ASX:PYC
34 GF Score
Price A$1.56
! 2 Warning Signs
View Full Analysis

What is PYC Therapeutics Retained Earnings?

PYC Therapeutics ASX:PYC +1.97% 34 Retained Earnings is A$-229.03 Mil as of Dec. 2025. GuruFocus rates ASX:PYC with a GF Score™ of 34/100. The stock has 2 warning signs investors should review.

Retained earnings is the accumulated portion of net income that is not distributed to shareholders. PYC Therapeutics's retained earnings for the quarter that ended in Dec. 2025 was A$-229.03 Mil.

PYC Therapeutics's quarterly retained earnings declined from Dec. 2024 (A$-181.47 Mil) to Jun. 2025 (A$-206.20 Mil) and declined from Jun. 2025 (A$-206.20 Mil) to Dec. 2025 (A$-229.03 Mil).

PYC Therapeutics's annual retained earnings declined from Jun. 2023 (A$-118.17 Mil) to Jun. 2024 (A$-155.90 Mil) and declined from Jun. 2024 (A$-155.90 Mil) to Jun. 2025 (A$-206.20 Mil).


PYC Therapeutics  (ASX:PYC) Retained Earnings Explanation

Historically profitable companies sometimes have negative retained earnings. This is because they have cumulatively paid out more to shareholders than they reported in profits.

For example, in 2011, Microsoft had negative retained earnings. This does not mean the company lost more money than it made over the years. It just means it paid out more money than it earned.

If a company has negative retained earnings, investors should check the 10-year financial results. They should not assume that negative retained earnings prove a company has generally lost money in the past.

Of course, many companies with negative retained earnings have indeed lost money in the past.

Retained Earnings: Warren Buffett's Secret.

One of the most important indicators of durable competitive advantage. Net earnings can be paid out as dividends, used to buy back shares or retained for growth.

If the company loses more than it has accumulated, retained earnings is negative.

If a company isn't adding to its retained earnings, it isn't growing its net worth.

Rate of growth of retained earnings is good indicator whether it's benefiting from a competitive advantage.

Microsoft is negative because it chose to buyback stock and pay dividends.

The more earnings retained, the faster it grows and increases growth rate for future earnings.


PYC Therapeutics Retained Earnings Historical Data

* Premium members only.

The historical data trend for PYC Therapeutics's Retained Earnings can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

PYC Therapeutics Retained Earnings Chart

PYC Therapeutics Annual Data
Trend Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24 Jun25
Retained Earnings
Get a 7-Day Free Trial Premium Member Only Premium Member Only -81.52 -95.38 -118.17 -155.90 -206.20

PYC Therapeutics Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Retained Earnings Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -133.26 -155.90 -181.47 -206.20 -229.03
ASX:PYC
34GF Score
PYC Therapeutics Ltd ASX:PYC
Retained Earnings is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

PYC Therapeutics Retained Earnings Calculation

Retained Earnings is the accumulated portion of net income that is not distributed to shareholders. Because the net income was not distributed to shareholders, shareholders' equity is increased by the same amount.

Of course, if a company loses, it is called retained losses, or accumulated losses.

Frequently Asked Questions Learn more about Retained Earnings →
What does a Retained Earnings of A$-229.03 Mil mean?
PYC Therapeutics (ASX:PYC) has a Retained Earnings of A$-229.03 Mil as of Dec. 2025. Retained earnings is the amount of net income not issued to shareholders. View historical data on PYC Therapeutics and its competitors.
Is PYC Therapeutics' Retained Earnings too high?
PYC Therapeutics' current Retained Earnings is A$-229.03 Mil. Overall, PYC Therapeutics has a GF Score™ of 34/100, reflecting its overall financial health beyond just this single metric.
How does PYC Therapeutics' Retained Earnings compare to VRTX and REGN?
PYC Therapeutics' Retained Earnings of A$-229.03 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Retained Earnings for a Biotechnology company?
A good Retained Earnings depends on the Biotechnology industry context. However, Retained Earnings should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Retained Earnings mean?
A high Retained Earnings can signal that a stock is expensive relative to its fundamentals. Retained earnings is the amount of net income not issued to shareholders. View historical data on PYC Therapeutics and its competitors. PYC Therapeutics's current Retained Earnings is A$-229.03 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PYC Therapeutics stock overvalued right now?
PYC Therapeutics (ASX:PYC) has a current Retained Earnings of A$-229.03 Mil. The current Retained Earnings is A$-229.03 Mil. PYC Therapeutics' overall GF Score™ is 34/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Retained Earnings calculated?
Retained Earnings is calculated from a company's financial statements. For PYC Therapeutics (ASX:PYC), the current Retained Earnings is A$-229.03 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

PYC Therapeutics Business Description

Other Exchanges PYCXF:USA
Address 6 Verdun Street, Harry Perkins Institute of Medical Research, Nedlands, Perth, WA, AUS, 6009
PYC Therapeutics Ltd is an RNA therapeutics drug development company, leveraging a proprietary delivery platform to solve the challenges in RNA therapeutics - safe and effective delivery of the drug inside the cell. The company's principal business activity is of of drug development and progressing the company's drug pipeline through preclinical and clinical development. Geographically, it operates only in Australia.
34GF Score

Get the complete analysis for ASX:PYC

Retained Earnings is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

A$1.56
Price